artery was prominent. In venous phase (VP), the lesion was isodense and the central scar was hypodense similar to those in AP. In equilibrium phase (EP), the lesion was isodense; however, the central scar and pseudocapsule were hyperdense.
Gray-scale ultrasound-guided core-needle biopsy was performed in the operation room, and FNH was pathologically confirmed (Figure 1 ).
After the pathological confirmation of FNH, the patient was followed up using periodic CT scanning (Figure 2 After 2008, US and LETs were used for follow-up, and CT imaging was performed in case of changes in LET findings or abdominal discomfort.
For CT imaging, ProntoSE CT scanner (Hitachi, Tokyo, Japan) with a single detector was used from 2003 to 2008 and Brilliance 64-channel multidetector CT systems (Philips, Koninklijke, Netherland) were used in 2013 and 2015. A low-dose CT protocol was used for examining the pediatric abdomen in the first half of the follow-up period.
Dynamic CT examinations with four phases were performed using low-dose pediatric protocol: NP and AP with 25-s delay, VP with 60-s delay, and EP with 10-min delay times after administering 100-mL nonionic iodinated contrast media with DP-9900 (Mindray, Shenzen, China), HD11 (Philips Ultrasound, Bothell, WA), and Applio (Toshiba, Tokyo, Japan) ultrasound systems with a 2-6-MHz broadband convex transducer were used for US imaging.
Focal nodular hyperplasia was located in the Couinaud segments IVa, IVb, V, and VIII.
The FNH volume was calculated using the three-dimensional ellipsoid formula: length (L)×width (W)×anteroposterior diameter (APD)×0.523 (1) . L was determined from the cephalocaudal axis; W and APD were measured in the axial plane slice which was showing the largest diameter of the lesion. Since liver enzyme levels began increasing in 2013, a CT scanning was performed again. However, all LET revealed normal findings in 2 weeks, which continued for 2 years (Figure 4 ).
After the third scanning, a selective feeding artery embolization was attempted to reduce the lesion volume in the autumn of 2004 (the thick gray arrow in Figure 5 ). However, the procedure could not be completed due to excessive pain despite administering sedoanalgesia. In 2015, the patient claimed that he noticed some changes in his abdomen while palpation. His abdomen was examined by using US and CT. Unexpectedly, caudal exophytic growth from segment 4b to segment 5 and distortion of the hepatic contour of the lesion were completely regressed and hepatic capsular retraction was detected for the first time in 144 months of follow-up (Figure 2,3,6,7) .
The patient provided informed consent for publication.
DISCUSSION
Focal nodular hyperplasia is the second most common benign tumor of liver after hemangiomas and constitutes 4% of all primary hepatic tumors in pediatric population (2). The patient was followed up by using not only CT and US, but also blood tests. US is an operator-dependent imaging modality and is difficult to standardize for measurements. In addition, the MRI scanner could not be used. Because installed MRI scanner in our radiology department was 0.35-T open-shield system and was not suitable for abdominal imaging. Therefore, we determined that CT was the most suitable among all the imaging modalities available in the department. In 2008, surgical treatment was planned because of voluminous increase in the mass. However, the patient refused surgery, and his LET findings were normal; therefore, "wait and see" approach was preferred.
Our case has unique features. Firstly, it is the longest followed up FNH from childhood to adulthood in the literature, and secondly, imaging and blood LET findings were correlated. Changes in the FNH lesion volume and LET findings were inversely related, i.e., when the lesion volume increased, AST and ALT levels were almost normal, and when the volume decreased, AST, ALT, and especially GGT levels peaked. Thirdly, FNH was considered in the differential diagnosis of hepatic capsular retraction for the first time in the literature ( Figure  2 ,3,6,7).
Bonney et al. (3) used persistence of pain as the main indication for surgery in FNH patients (3)
. However, pain is a subjective and relative symptom depending on personal tolerance of the patients. Their study could not clearly demonstrate how many patients with pain had elevated liver enzyme levels.
In the medical literature, the natural course of FNH has been reported to be variable, which is presented in Figure 8 (4-8) .
In their study, Kuo et al. (4) demonstrated that 9% (18% with regressed lesions) of FNH lesions disappeared, whereas Di Stasi et al. (5) reported that 6% of FNH lesions disappeared and found no progression of the lesions. However, we believe that the FNH lesion size can be seen increasing or decreasing depending on the follow-up duration time of the lesions, e.g, if this case was followed between 2004 and 2007, it could be decided as an enlarging space occupying lesion. On the other hand, if the follow-up period was taken into account between 2008 and 2013, it could be decided as regressing space occupying lesion. Volume changes figure supports that idea ( Figure 5 ).
In our case, the lesion volume began decreasing in 2008 and regressed in 2015 ( Figure 5 ). It is not well understood whether the FNH regressed due to embolization or spontaneously. We do not think that the regression occurred due to embolization because of the long time interval between embolization and reduction in volume. We considered apoptosis as the possible explanation for regression. Apoptosis is a process of programmed cell death (9, 10) . Apoptotic cells die in a controlled and regulated fashion; therefore, apoptosis is distinct from other uncontrolled cell death processes, such as necrosis, necroptosis, autophagy, and cornification (9) . Apoptosis involves death of a single cell or small clusters of cells without inflammatory response (9).
The feeding artery was coursing through lateral side of the lesion, and we considered that it was gradually compressed between the enlarging lesion and normal hepatic parenchyma. The feeding artery was clearly visible in the CT scan performed in 2013 but not in the CT scan performed in 2015 (Figure 6,7) . Therefore, we propose that regression of the FNH lesion occurs due to ischemia, which may trigger the apoptosis process, caused by the compression of the feeding artery. We also considered that increase in liver enzyme levels may be due to ischemia and cell apoptosis in FNH.
To the best of our knowledge, hepatic capsular retraction in the natural course of FNH has not been described in the literature; it should be kept in mind in the differential diagnosis of a liver lesion causing hepatic capsular retraction and of a liver lesion with exophytic growth and atypical enhancement and density pattern.
The surgical treatment of choice should be decided based on the findings of not only imaging modalities but also liver enzyme levels, especially GGT levels. If the lesion volume is increasing and there is no increase in the GGT level or if the lesion volume is decreasing and the GGT level is increasing, follow-up should be continued until a decrease is observed in both.
In conclusion, in addition to imaging modalities, it is logical to follow-up an FNH lesion using tests for AST, ALT, and especially GGT levels. Future studies involving more number of patients are needed.
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